NARATRIPTAN EG 2.5 mg, film-coated tablet 6 tablets
Active ingredients: Naratriptan hydrochloride, Naratriptan
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet6 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NARATRIPTAN EG 2,5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide aluminium PVC-Aluminium de 6 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 Jun 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68686698CIP74936299CIP133400949362998Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NARATRIPTANcomprimé | 2,5 mg · un comprimé | FT |
| CHLORHYDRATE DE NARATRIPTANcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.